Andrew Abaasa
Biographic Data
| ID | 7728341 |
|---|---|
| NAME | Andrew Abaasa |
| GIVEN NAMES | Andrew |
| FAMILY NAME | Abaasa |
| SIGNATURE | ABAASA A |
| AFFILIATIONS | Uganda Virus Research Institute |
| ORCID | 0000-0002-6770-5588 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Knowledge, perceptions and practices of parents and community members on sudden unexpected infant death in Central Uganda
Background Sudden unexpected infant death (SUID) remains poorly documented in Uganda. We explored parental and community knowledge, perceptions, and practices related to SUID in Uganda. Methods: In 2024, we conducted a qualitative cross-sectional study in Central Uganda involving 41 in-depth interviews (IDI) with mothers (8 cases, 8 controls), fathers (5 cases, 5 controls), and 15 female advisors selected by mothers. Cases were parents who had lo…
Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
We examined the effect of the Universal Test and Treat (UTT) policy on the characteristics of people living with HIV (PLHIV) at enrolment in HIV care and initiation of antiretroviral therapy (ART) in Uganda using data from 11 nationally representative clinics of The AIDS Support Organisation (TASO). We created two retrospective PLHIV cohorts: pre-UTT (2004–2016), where ART initiation was conditional on CD4 cell count and UTT (2017–2022), where AR…
Feasibility and acceptability of using biometric fingerprinting to track migrations and support retention in HIV prevention research in fishing population in East Africa
Use of fingerprinting in fishing populations is feasible and acceptable. It is possible to track this mobile population for clinical trials or health services using this technology since most movements could be traced within and between villages
Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
Our findings suggest that it is possible to conduct HIV prevention trials among key populations in Nairobi with a good adherence to a vaccine efficacy trial schedule. Despite HIV prevention efforts, we also noted a high incidence of HIV infection. This demonstrates the need for effective HIV prevention products in these populations
Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials
FSWs in Kampala demonstrated high WTP. Prior experience with trial requirements like contraception may improve their uptake during actual trials. Family involvement is important for those without prior trial experience
Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda
Many key populations have high-risk behaviors for HIV infection making them suitable for HIV vaccine efficacy trials. However, these behaviors may change when participants enroll into a trial. We used HIV simulated vaccine efficacy trials (SiVETs) nested within observational cohorts of fisherfolks and female sex workers in Uganda to evaluate this difference. We screened observational cohort participants for enrolment into SiVETs, until 572 were e…
Prevalence and Factors Associated with Contraceptive Use Among Kenyan Women Aged 15–49 Years
Contraceptive Preference Among Women at Risk of HIV Acquisition in a Preparatory Screening Study for a Phase III Microbicide Trial in South Western Uganda
Utility of Different Adherence Measures for PrEP
Measuring PrEP adherence remains challenging. In 2009-2010, the International AIDS Vaccine Initiative randomized phase II trial participants to daily tenofovir disoproxil fumarate/emtricitabine or placebo in Uganda and Kenya. Adherence was measured by electronic monitoring (EM), self-report (SR), and drug concentrations in plasma and hair. Each adherence measure was categorised as low, moderate, or high and also considered continuously; the incre…
No prominent works on this page.
Utility of Different Adherence Measures for PrEP
Measuring PrEP adherence remains challenging. In 2009-2010, the International AIDS Vaccine Initiative randomized phase II trial participants to daily tenofovir disoproxil fumarate/emtricitabine or placebo in Uganda and Kenya. Adherence was measured by electronic monitoring (EM), self-report (SR), and drug concentrations in plasma and hair. Each adherence measure was categorised as low, moderate, or high and also considered continuously; the incre…
Prevalence and Factors Associated with Contraceptive Use Among Kenyan Women Aged 15–49 Years
Contraceptive Preference Among Women at Risk of HIV Acquisition in a Preparatory Screening Study for a Phase III Microbicide Trial in South Western Uganda
Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials
FSWs in Kampala demonstrated high WTP. Prior experience with trial requirements like contraception may improve their uptake during actual trials. Family involvement is important for those without prior trial experience
Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda
Many key populations have high-risk behaviors for HIV infection making them suitable for HIV vaccine efficacy trials. However, these behaviors may change when participants enroll into a trial. We used HIV simulated vaccine efficacy trials (SiVETs) nested within observational cohorts of fisherfolks and female sex workers in Uganda to evaluate this difference. We screened observational cohort participants for enrolment into SiVETs, until 572 were e…
Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
Our findings suggest that it is possible to conduct HIV prevention trials among key populations in Nairobi with a good adherence to a vaccine efficacy trial schedule. Despite HIV prevention efforts, we also noted a high incidence of HIV infection. This demonstrates the need for effective HIV prevention products in these populations
Effect of the “universal test and treat” policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda
We examined the effect of the Universal Test and Treat (UTT) policy on the characteristics of people living with HIV (PLHIV) at enrolment in HIV care and initiation of antiretroviral therapy (ART) in Uganda using data from 11 nationally representative clinics of The AIDS Support Organisation (TASO). We created two retrospective PLHIV cohorts: pre-UTT (2004–2016), where ART initiation was conditional on CD4 cell count and UTT (2017–2022), where AR…
Feasibility and acceptability of using biometric fingerprinting to track migrations and support retention in HIV prevention research in fishing population in East Africa
Use of fingerprinting in fishing populations is feasible and acceptable. It is possible to track this mobile population for clinical trials or health services using this technology since most movements could be traced within and between villages
Knowledge, perceptions and practices of parents and community members on sudden unexpected infant death in Central Uganda
Background Sudden unexpected infant death (SUID) remains poorly documented in Uganda. We explored parental and community knowledge, perceptions, and practices related to SUID in Uganda. Methods: In 2024, we conducted a qualitative cross-sectional study in Central Uganda involving 41 in-depth interviews (IDI) with mothers (8 cases, 8 controls), fathers (5 cases, 5 controls), and 15 female advisors selected by mothers. Cases were parents who had lo…
Medicine (8 works) · HIV/AIDS Research and Interventions (7 works) · Public health (7 works) · Demography (5 works) · Demography (5 works) · HIV, Drug Use, Sexual Risk (5 works) · Environmental health (4 works) · Family medicine (4 works) · Human immunodeficiency virus (HIV (4 works) · Internal Medicine (4 works)